Martin Schaefer

Title: Martin Schaefer: Innovator in Therapeutic Antibodies

Introduction

Martin Schaefer is a notable inventor based in Penzberg, Germany. He has made significant contributions to the field of therapeutic antibodies, holding a total of 3 patents. His work focuses on innovative solutions for treating various diseases, including cancers and autoimmune disorders.

Latest Patents

Schaefer's latest patents include groundbreaking inventions such as bispecific anti-CCL2 antibodies. This invention relates to antibodies that bind to two different epitopes on human CCL2, along with pharmaceutical compositions and their use as medicaments for treating cancers, inflammatory, autoimmune, and ophthalmologic diseases. Another significant patent is a method for determining the amount of a therapeutic antibody in the brain. This method reduces interference from residual blood in tissue samples by applying an inert reference antibody prior to obtaining the samples, enhancing the accuracy of therapeutic antibody concentration measurements.

Career Highlights

Throughout his career, Martin Schaefer has worked with prominent companies, including Hoffmann-La Roche Inc. and F. Hoffmann-La Roche AG. His experience in these organizations has allowed him to develop and refine his innovative ideas in the field of therapeutic antibodies.

Collaborations

Schaefer has collaborated with notable professionals in his field, including Gregor Jordan and Jens Fischer. These collaborations have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Martin Schaefer is a distinguished inventor whose work in therapeutic antibodies has the potential to significantly impact the treatment of various diseases. His innovative patents and collaborations highlight his commitment to advancing medical science.